search icon
dare-img

Dare Bioscience Inc, Common Stock

DARE

NAQ

$3.34

+$0.01

(0.3%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$29.06M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
21.09K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.34
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.67 L
$7.56 H
$3.34

About Dare Bioscience Inc, Common Stock

Daré Bioscience, Inc., a biopharmaceutical company, identifies, develops, and markets products for women's health in the United States. It develops therapies in the areas of contraception, reproductive health, menopause, fertility, and sexual and vaginal health. The company offers XACIATO for the treatment of bacterial vaginosis in female patients 12 years of age and older. It is developing Ovaprene, a hormone-free, monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia on demand for the treatment of female sexual arousal disorder; DARE-HRT1 to treat moderate to-severe vasomotor symptoms in menopausal hormone therapy; DARE-VVA1 for the treatment of moderate-to-severe dyspareunia or pain during sexual intercourse; and DARE-CIN to treat cervical intraepithelial neoplasia and other human papillomavirus related pathologies. The company is also developing DARE-PDM1 for the treatment of primary dysmenorrhea; DARE-204 and DARE-214, an injectable formulations contraception of etonogestrel designed to provide contraception over 6-month and 12-month periods; DARE-FRT1, an intravaginal ring designed to deliver bio-identical progesterone for luteal phase support as part of an in vitro fertilization treatment plan; and DARE-PTB1 for the prevention of preterm birth. In addition, it is developing DARE-LARC1, a contraceptive implant delivering levonorgestrel with a woman-centered design that controlled contraceptive option; DARE-LBT, a novel hydrogel formulation for vaginal delivery of live biotherapeutics to support vaginal health; DARE-GML, a multi-target antimicrobial agent; DARE-RH1, a novel approach to non-hormonal contraception for men and women by targeting the CatSper ion channel; and DARE-PTB2 for the prevention and treatment of idiopathic preterm birth through inhibition of a stress response protein. Daré Bioscience, Inc. is headquartered in San Diego, California. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameDARESectorS&P500
1-Week Return-1.18%0.31%-1.26%
1-Month Return5.03%0.6%-4.16%
3-Month Return-5.38%-9.44%-0.46%
6-Month Return-1.18%-5.15%3.58%
1-Year Return-14.09%0.33%22.47%
3-Year Return-83.23%4.53%25.13%
5-Year Return-79.68%35.98%77.7%
10-Year Return-99.66%100.72%190.12%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue--10.00M10.00M2.81M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":28.08,"profit":true}]
Cost of Revenue11.14K43.23K26.41K47.62K38.36K[{"date":"2019-12-31","value":23.39,"profit":true},{"date":"2020-12-31","value":90.78,"profit":true},{"date":"2021-12-31","value":55.47,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":80.57,"profit":true}]
Gross Profit(11.14K)(43.23K)(26.41K)10.00M2.77M[{"date":"2019-12-31","value":-0.11,"profit":false},{"date":"2020-12-31","value":-0.43,"profit":false},{"date":"2021-12-31","value":-0.26,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":27.7,"profit":true}]
Gross Margin(Infinity%)(Infinity%)(0.26%)100.00%98.63%[{"date":"2019-12-31","value":null,"profit":false},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":-0.26,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.63,"profit":true}]
Operating Expenses14.34M27.40M39.07M41.39M33.61M[{"date":"2019-12-31","value":34.66,"profit":true},{"date":"2020-12-31","value":66.21,"profit":true},{"date":"2021-12-31","value":94.4,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":81.21,"profit":true}]
Operating Income(14.34M)(27.40M)(39.07M)(31.39M)(30.84M)[{"date":"2019-12-31","value":-1434488000,"profit":false},{"date":"2020-12-31","value":-2740225700,"profit":false},{"date":"2021-12-31","value":-3906851200,"profit":false},{"date":"2022-12-31","value":-3138548800,"profit":false},{"date":"2023-12-31","value":-3083988000,"profit":false}]
Total Non-Operating Income/Expense-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income(14.26M)(27.40M)(38.70M)(30.95M)(30.16M)[{"date":"2019-12-31","value":-1426383000,"profit":false},{"date":"2020-12-31","value":-2740074300,"profit":false},{"date":"2021-12-31","value":-3869610500,"profit":false},{"date":"2022-12-31","value":-3094773800,"profit":false},{"date":"2023-12-31","value":-3016139100,"profit":false}]
Income Taxes(81.05K)(163.07K)(369.89K)(437.75M)(3.00)[{"date":"2019-12-31","value":-8105000,"profit":false},{"date":"2020-12-31","value":-16307000,"profit":false},{"date":"2021-12-31","value":-36988700,"profit":false},{"date":"2022-12-31","value":-43775000000,"profit":false},{"date":"2023-12-31","value":-300,"profit":false}]
Income After Taxes-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(14.26M)(27.40M)(38.70M)(30.95M)(41.05M)[{"date":"2019-12-31","value":-1426383000,"profit":false},{"date":"2020-12-31","value":-2740074300,"profit":false},{"date":"2021-12-31","value":-3869610500,"profit":false},{"date":"2022-12-31","value":-3094773800,"profit":false},{"date":"2023-12-31","value":-4104705200,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(14.26M)(27.40M)(38.33M)406.80M(30.16M)[{"date":"2019-12-31","value":-3.51,"profit":false},{"date":"2020-12-31","value":-6.74,"profit":false},{"date":"2021-12-31","value":-9.42,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-7.41,"profit":false}]
EPS (Diluted)(0.95)(0.97)(0.71)(0.37)(0.34)[{"date":"2019-12-31","value":-95,"profit":false},{"date":"2020-12-31","value":-97,"profit":false},{"date":"2021-12-31","value":-71,"profit":false},{"date":"2022-12-31","value":-36.52,"profit":false},{"date":"2023-12-31","value":-34,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

DARE
Cash Ratio 0.85
Current Ratio 1.14

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

DARE
ROA (LTM) -71.42%
ROE (LTM) -994.69%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

DARE
Debt Ratio Lower is generally better. Negative is bad. 1.08
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.08

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

DARE
Trailing PE NM
Forward PE NM
P/S (TTM) 10.20
P/B 10.75
Price/FCF NM
EV/R 10.18
EV/Ebitda NM
PEG NM

FAQs

What is Dare Bioscience Inc share price today?

Dare Bioscience Inc (DARE) share price today is $3.34

Can Indians buy Dare Bioscience Inc shares?

Yes, Indians can buy shares of Dare Bioscience Inc (DARE) on Vested. To buy Dare Bioscience Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in DARE stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Dare Bioscience Inc be purchased?

Yes, you can purchase fractional shares of Dare Bioscience Inc (DARE) via the Vested app. You can start investing in Dare Bioscience Inc (DARE) with a minimum investment of $1.

How to invest in Dare Bioscience Inc shares from India?

You can invest in shares of Dare Bioscience Inc (DARE) via Vested in three simple steps:

  • Click on Sign Up or Invest in DARE stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Dare Bioscience Inc shares
What is Dare Bioscience Inc 52-week high and low stock price?

The 52-week high price of Dare Bioscience Inc (DARE) is $7.56. The 52-week low price of Dare Bioscience Inc (DARE) is $2.67.

What is Dare Bioscience Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Dare Bioscience Inc (DARE) is

What is Dare Bioscience Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Dare Bioscience Inc (DARE) is 10.75

What is Dare Bioscience Inc dividend yield?

The dividend yield of Dare Bioscience Inc (DARE) is 0.00%

What is the Market Cap of Dare Bioscience Inc?

The market capitalization of Dare Bioscience Inc (DARE) is $29.06M

What is Dare Bioscience Inc’s stock symbol?

The stock symbol (or ticker) of Dare Bioscience Inc is DARE

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top